KetLace Biosciences ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About KetLace Biosciences ApS
KetLace Biosciences ApS (CVR number: 43340743) is a company from AARHUS. The company recorded a gross profit of -14.6 kDKK in 2022. The operating profit was -14.6 kDKK, while net earnings were -12.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -10.8 %, which can be considered poor and Return on Equity (ROE) was -45 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 20.5 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. KetLace Biosciences ApS's liquidity measured by quick ratio was 19.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2022 | |
---|---|
Volume | |
Net sales | |
Gross profit | -14.58 |
EBIT | -14.58 |
Net earnings | -12.41 |
Shareholders equity total | 27.59 |
Balance sheet total (assets) | 134.39 |
Net debt | -30.82 |
Profitability | |
EBIT-% | |
ROA | -10.8 % |
ROE | -45.0 % |
ROI | -11.4 % |
Economic value added (EVA) | -12.32 |
Solvency | |
Equity ratio | 20.5 % |
Gearing | 362.4 % |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 19.8 |
Current ratio | 19.8 |
Cash and cash equivalents | 130.82 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.